Nanoscope Therapeutics
Bedford, US · Founded 2017 · Delaware corporation
Find your way into Nanoscope Therapeutics
Nanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
Founders & leadership
Nanoscope Therapeutics was founded in 2017 by Samarendra Mohanty and Sulagna Bhattacharya.
Reported raises · per SEC filings
Form D private placements$12.8M disclosed across 1 round · 2020
▶$12.8MraisedJul 2020 · 12 investors · Other Health CareRule 506(b)
▶$12.8MraisedJul 2020 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Samarendra MohantyExecutive Officer, Director
- Sulagna BhattacharyaExecutive Officer, Director
- Alvaro GuillemDirector
- Offering amount
- $16.1M
- Amount sold
- $12.8M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nanoscope Therapeutics do?
- Nanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
- Who founded Nanoscope Therapeutics?
- Nanoscope Therapeutics was founded by Samarendra Mohanty, Sulagna Bhattacharya in 2017.
- How much funding has Nanoscope Therapeutics raised?
- Nanoscope Therapeutics has disclosed $12.8M raised across 1 round.
- Where is Nanoscope Therapeutics headquartered?
- Nanoscope Therapeutics is headquartered in Bedford, US.